Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection

Published:2003-01 Issue:1 Volume:57 Page:4-14
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Richardson Max W,Mirchandani Jyotika,Duong Joseph,Grimaldo Sammy,Kocieda Virginia,Hendel Houria,Khalili Kamel,Zagury Jean-François,Rappaport Jay

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference71 articles.

1. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals;Addo;Proc Natl Acad Sci USA,2001

2. Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication;Allen;J Virol,2002

3. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia;Allen;Nature,2000

4. Vpr is preferentially targeted by CTL during HIV-1 infection;Altfeld;J Immunol,2001

5. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III);Arya;Science,1985

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis;International Journal of Molecular Sciences;2024-01-30

2. Identification of viral protein R of human immunodeficiency virus-1 (HIV) and interleukin-6 as risk factors for malignancies in HIV-infected individuals: A cohort study;PLOS ONE;2024-01-02

3. HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine;Expert Review of Vaccines;2022-06-17

4. New insights into pathogenesis point to HIV-1 Tat as a key vaccine target;Archives of Virology;2021-08-14

5. Physicochemical studies on the structural stability of the HIV-1 vaccine candidate recombinant Tat protein;International Journal of Biological Macromolecules;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3